CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2– positive metastatic breast cancer
Author
Bergin Alice R.T.
Bujak Andjelija Zivanovic
+29Â more
Dawson Sarah Jane
Desai Jayesh
Ftouni Sarah
Gandolfo Luke C.
Gray Daniel H.D.
Liew Danny
Lindeman Geoffrey J.
Liu He K.
Lo Louisa L.
Lok Sheau W.
Mann G. Bruce
Moodie Kate
Murugasu Anand
Pal Bhupinder
Policheni Antonia N.
Roberts Andrew W.
Rosenthal Mark A.
Shackleton Kylie
Silva Maria João
Siow Zhen R.
Smyth Gordon K.
Taylor Leanne
Teh Charis E.
Travers Avraham
Vaillant François
Visvader Jane E.
Whittle James R.
Yeo Belinda
Yeung Miriam M.
Publication venue
'American Association for Cancer Research (AACR)'
Publication date
01/03/2019
Field of study
No full text
Monash University Research Portal